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Abstract
The possible utility of Bayesian methods for the synthesis of qualitative and quantitative research
has been repeatedly suggested but insufficiently investigated. In this project, we developed and
used a Bayesian method for synthesis, with the goal of identifying factors that influence adherence
to HIV medication regimens. We investigated the effect of 10 factors on adherence. Recognizing
that not all factors were examined in all studies, we considered standard methods for dealing with
missing data and chose a Bayesian data augmentation method. We were able to summarize, rank,
and compare the effects of each of the 10 factors on medication adherence. This is a promising
methodological development in the synthesis of qualitative and quantitative research.
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1 Introduction
Among the challenges to conducting comprehensive systematic reviews of research in the
health, behavioral, and social sciences is how best to synthesize the findings from
methodologically diverse studies. A spate of literature over the past decade has been focused
on describing the issues raised in, proposing methods for, and reporting the results of
reviews directed toward integrating qualitative and quantitative research findings (e.g.,
Dixon-Woods et al. 2005; Harden and Thomas 2005; Pope et al. 2007; Voils et al. 2009).
The possibility of using Bayesian methods to integrate qualitative and quantitative research
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is mentioned repeatedly in this literature; however, there remains only one published
example of the actual use of a Bayesian approach to synthesize qualitative and quantitative
evidence (Roberts et al. 2002). Recognizing the need for further research in this area, we
described a second Bayesian method for synthesis in a paper currently under review (Voils
et al. 2009). In this article, we describe a third method and compare it to these other two
Bayesian approaches.
1.1 Orientations to incorporating qualitative research into systematic reviews
What constitutes a synthesis of research, and even qualitative as opposed to quantitative
research, is still the subject of methodological debate, with proponents of qualitative
research most concerned about the co-optation of qualitative research imperatives to
quantitative research standards, and proponents of quantitative research most concerned
about maintaining those standards of empirical research (e.g., Barbour and Barbour 2003;
Hammersley 2002; Sandelowski et al. 2007). A comprehensive review of these debates is
beyond the scope of this article. Accordingly, for our purposes here, we define research
synthesis as the actual fusion of qualitative with quantitative evidence—the assimilation of
one into the other—as opposed to including or comparing qualitative and quantitative
research findings in one systematic review. Although we find the continued binary
distinction between qualitative and quantitative research regrettable, we use these terms here
as a shorthand communication of the difference between studies directed toward narrative
understandings, and range of possibilities, of a target phenomenon (qualitative), and those
directed toward ascertaining prevalence and probable influence of one or more pre-specified
variables on one or more other pre-specified variables signifying that phenomenon
(quantitative).
With these definitions and distinctions in mind, qualitative research can be said to be
incorporated into systematic reviews at three different points: before any synthesis of
information, as part of the synthesized information, or as a framework in which to interpret
synthesized information. Incorporating qualitative evidence before the synthesis involves
using it to inform the process, for example, to pose an appropriate research question for a
systematic review of the quantitative literature and/or to determine elements of the design to
answer the research question, such as properties of the sample(s)and the variables of interest.
This reflects a still common understanding of qualitative research as precursor to
quantitative research whereby the use of qualitative evidence is limited to generating, but
not answering, research questions. Incorporating qualitative evidence at the end of a review,
to interpret quantitative results, also places limits on its contribution to the results
themselves. If researchers wish to treat qualitative evidence as data along with quantitative
evidence, rather than as before or after accessories, the qualitative evidence should be
allowed to contribute directly to—that is, to shape—the results of the systematic review.
One way to do this involves integrating the findings from qualitative and quantitative studies
separately and then using the results of these two separate analyses to inform the aggregated
evidence. This can be done with existing methods if the final synthesis of results is done
non-mathematically (see Goldsmith et al. 2007).
A mathematical synthesis of qualitative and qualitative evidence has been performed by
Roberts et al. (2002), who described a Bayesian approach they used to identify factors
affecting the uptake of childhood immunization. They used evidence from the qualitative
studies as prior information, allowing it to inform about which factors might be related to
the uptake of immunization in children. Findings from the qualitative studies were tabulated
and combined with their own expert opinion to estimate the prior probability that each factor
was related to receiving immunization. They then used evidence from the quantitative
studies on the same topic to update these prior probabilities, yielding posterior probabilities
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that each factor was associated with the decision to immunize. In short, Roberts et al.
incorporated information from the qualitative studies at the start of their analysis. They
synthesized the qualitative information to get prior probabilities of the relationships and then
updated these with evidence from the quantitative studies.
In response to the Roberts et al. (2002) effort, we (Voils et al. 2009) observed that the
approach they used did not treat the qualitative evidence with as much weight as the
quantitative evidence, and proposed that it be incorporated into the same stage of the
analysis as the quantitative evidence to allow both to equally inform about the results. The
main challenge in incorporating qualitative and quantitative data at the same stage of the
analysis is that, in order for the two types of information to be incorporated in the same way,
they must be transformed so that they can be combined.
In Voils et al. (2009), we used qualitative and quantitative observational studies on
antiretroviral adherence to determine whether a more complex medication regimen was
associated with increased adherence. To make the two types of evidence compatible, the
findings in the qualitative studies were quantified using a set of strategies, described in
Chang et al. (2009), for inferring the frequencies of findings from reports of qualitative
descriptive studies that did not offer this information in numbers. Information about finding
frequencies was extracted from the qualitative reports by transforming verbal counts (e.g.,
few, many) into numbers. The finding frequencies were designated as ranges because the
actual numbers were not available, which is often the case in qualitative research reports
(although not necessarily a deficiency in qualitative reports (see Chang et al. (2009)). These
frequency ranges were synthesized in the same way as the findings frequencies from the
quantitative studies to estimate the probability that, for a given research participant, regimen
complexity was associated with increased adherence. To study the feasibility of synthesis
under these conditions, the data were synthesized separately for the qualitative and
quantitative studies. The two study types yielded different estimates of the probability of an
association. We hypothesized that this was due either to the method used to extract findings
frequencies, or to differences between subject-level probabilities of association in qualitative
and quantitative studies. Yet, this approach was explicit in its attempt to give the same
treatment to the frequency data extracted from both the qualitative and quantitative studies.
In the analysis featured in this article, our goal was to perform a different type of Bayesian
synthesis that still allowed for the same treatment of quantitative and qualitative reports. In
Voils et al. (2009), we made the two types of evidence compatible by extracting subject-
level quantitative information from qualitative reports, effectively quantitizing the
qualitative evidence. In the current project, motivated in part by the lack of availability of
subject-level information in the qualitative reports, we chose instead to look at all reports on
the study level. We translated the numerical results of the quantitative papers into themes,
categorizing each report according to the presence/absence of themes. Once the themes were
extracted from the qualitative and quantitative reports, a Bayesian data augmentation
method was used to summarize the findings. We now describe this Bayesian synthesis of
qualitative and quantitative research findings.
2 Methods
2.1 Collecting research reports
The research reports used in the analysis featured here were collected as part of an ongoing
methodological study directed toward developing methods to synthesize qualitative and
quantitative research findings. The sample of reports included 12 reports of qualitative
descriptive studies and 15 reports of quantitative observational studies with finding related
to factors facilitating or hindering antiretroviral adherence. (Further information about the
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larger methodological study, including search criteria, are available from the last author on
request.)
2.2 Data abstraction
Examining the list of variables in both studies, we found that many variables were similar,
but not identical. This is typically the case in systematic reviews; it is usually necessary to
combine factors seen to be similar and, therefore, treatable as the same because otherwise,
there would be few findings available to synthesize, no matter what the method of synthesis
used. We grouped similar variables together; for example, the variables feeling ill, side
effects, and weight gain were all considered to be one factor called “side effects.” We ended
up with 12 factors potentially related to adherence to study.
2.3 Choosing the form of the data
We treated each research report as a case (Gerring 2007), coding each according to its
conclusions about the relationship between each of the factors and adherence. For the
quantitative studies, we used Cohen’s d (the standardized difference between means, a
commonly used effect size index) and applied criteria such that if d ≥ .20, it was coded as 1;
−.20 < d <.20, as .50; and d ≤ −.20, as 0. For the qualitative studies, if a variable was related
to adherence, it was coded as 1, if related to both adherence and nonadherence, or neither, it
was coded as .5, and, if related to nonadherence, it was coded as 0. For both types of studies,
if a report did not address a certain variable, the cell was left blank, as we were careful not to
assume a lack of effect of a variable that was not examined at all. An important difference
between qualitative and quantitative research is that in quantitative research, an a priori
decision is made concerning what variables will be studied. In contrast, in qualitative
research, whether a variable is addressed depends on what happens in the study, for
example, on how questions were asked, whether participants brought it up, or on whether
researchers chose to feature it.
We first created a data matrix (Table 1) summarizing the findings of all of the reports, with
each column corresponding to one of the selected variables and each row to a single report.
Entries were made in the matrix whenever a factor was reported as promoting adherence (1),
having no effect on adherence (0.5), or promoting nonadherence (0). Table 1 contains only
10 factors. We deleted two of the originally selected factors (substance abuse and good
relationship with healthcare provider) because there was no variability among study
findings: all studies that addressed these variables found that a good relationship with the
healthcare provider was associated with adherence and that substance abuse was associated
with nonadherence. The methods we describe are not applicable to factors with no
variability, because they rely on the estimation of a variance. The deletion of these factors
also led to the removal of two reports because they offered no results on any of the
remaining 10 factors.
Returning to Table 1, if each row is treated as an observation and each column as a variable,
the cells corresponding to the qualitative and quantitative studies for each of the 10 factors
can be treated as a dataset. Because any one report addressed only a small subset of the
variables studied across reports, a large proportion of the cells in the dataset remain empty.
2.4 A naive analysis
As shown in Table 1, a large proportion (75%) of cells contain no data. A very basic (naive)
analysis of these data could ignore the missing values, and then take the average of the non-
missing values in each column to estimate the strength of the relationship between each
variable and adherence or nonadherence to an antiretroviral regimen. For each factor, the
estimate describing the strength of association is the average of the non-missing cells in the
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column. A 95% confidence interval for each mean could also be constructed. This procedure
ignores reports that did not address the factor, which means that the number of reports on
which an estimate is based will vary from factor to factor. For example, for the association
between feeling ill and adherence/nonadherence, the estimate is (1 + .5 + .5)/12 = .17. These
naive estimates are shown in Table 2. As we noted previously, a value of zeroin the table
means that a factor is associated with nonadherence to the regimen, a value of .5 means
there is no association between the factor and adherence, and a value of 1 means that a
factor is associated with adherence. Under the assumption of normality, the 95% confidence
intervals will contain the “true” mean value for that variable 95% of the time. If a
confidence interval contains .5, there is not enough evidence categorically to state an
association with either adherence or nonadherence.
Because the number of observations used to construct each confidence interval is small, the
appropriateness of the confidence intervals is based on the unlikely assumption that the data
are normally distributed. The normal confidence interval makes no allowance for the fact
that the value must range from 0 to 1, so the confidence intervals are truncated to allow no
values outside this range; they are reported in the fourth column of Table 2 (i.e., a value <0
becomes 0, and a value >1 becomes 1).
This analysis allows us to draw a conclusion about the relationship between adherence and
each variable. For example, the confidence interval for the association between side effects/
feeling ill and adherence is (0, .35). This interval does not contain .5, so we would conclude
that side effects/feeling ill is associated with nonadherence. A belief that antiretroviral
medications might do harm is also associated with nonadherence, with an even narrower
confidence interval of (0, .25). In addition to the small sample sizes making the confidence
intervals unreliable, they also give us limited power to draw conclusions about the relative
strengths of these associations (i.e., examine whether a belief that antiretroviral medications
might do harm is a stronger predictor of nonadherence than side effects/feeling ill). To do
this, we would have had do a t-test (or nonparametric test) to compare means, and the
samples sizes are simply too small for powerful tests. In order to make adequate use of the
small amount of available information, we chose to use a more complex statistical
procedure.
2.5 A more rigorous analysis
2.5.1 Background—The naive analysis ignores cells in which the data were missing,
using standard methods of estimation to summarize the results in the non-missing cells. This
gives unsatisfactory results, as the resulting confidence intervals are based on very small
samples and the normality assumption, which is inappropriate.
Having recognized that our main problem was that we had only a small number of observed
cells in our dataset, we turned our attention first to standard methods for dealing with
missing data. This dataset—as we surmise will be the case with most research synthesis
datasets—has more missing data than a typical dataset from a primary research study;
therefore, the assumptions of these methods and their applicability to the current dataset
must be carefully considered. Broadly defined, there are two common methods for dealing
with missing data: complete case analysis and Bayesian data augmentation.
Complete case analysis: Complete case analysis involves deleting all cases that are
incomplete, then analyzing the rest (listwise deletion). Complete case analysis in research
synthesis projects is problematic in two ways. The first is enough to thwart most attempts to
use complete case analysis; that is, rarely will complete observations be available in a
research synthesis dataset. A complete case occurs only when investigators report results
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about all of the variables of interest, therefore, retaining only complete cases in our dataset
would have eliminated all of the observations.
A second problem is that complete case analysis can bias results if missing values are not
missing completely at random (MCAR). In this case, MCAR is true if the reports that did
not have findings about a given variable are in no way systematically different from the
reports that did have findings about the variable. This situation would arise if the variables
to include in each study were chosen completely at random, which is unlikely because large,
comprehensive studies probably have different aims and procedures than smaller, more
focused studies. Qualitative studies have more inclusive, open-ended aims and research
questions that function like a “compass,” while quantitative studies have more specific,
fixed aims that function like an “anchor” (Eakin and Mykhalovskiy 2003, p. 190).
Bayesian data augmentation: Whenever analyzing a dataset using complete case analysis
is deemed unacceptable due to excessive loss of data (i.e., few or no complete cases) and/or
possible violation of the MCAR assumption, there are several methods that can be employed
(Little and Rubin 2002). The most widely-used of these methods relies on employing the
available data to impute the values of the missing data with Bayesian methods, then
analyzing the data as if it were complete. The use of observed values to inform about
plausible missing values is called imputation and requires the assumption that all missing
values exist, but are not observed. Therefore, each row of the dataset must be conceived as a
vector, of which only a few elements are visible. Moreover, it must make sense for a value
to appear in each cell for which data are imputed.
The Bayesian data augmentation method that we used (Gelman et al. 2004) is relatively
straightforward to implement and is appropriate for any amount of missing data. This
method assumes that each row in the table, if completely observed, could be considered a
random vector drawn from some type of multivariate distribution. In reality, only a few
elements from each draw are observed (i.e., each vector is only partially observed). The data
augmentation procedure involves using the observed data to estimate the unknown
parameters of the multivariate distribution, then drawing from the distribution to estimate
the missing values themselves. The estimated missing values are then used to fill in the
empty cells in the dataset (the name, data augmentation, comes from the fact that observed
data are augmented with imputed data), and the parameters of the distribution are re-
estimated. This procedure is repeated until a large number of estimates have been obtained.
The estimates are then summarized to describe the parameters of the multivariate
distribution from which each row was drawn.
2.5.2 Details of the rigorous analysis—Each row of the table can be thought of as an
independent draw from a multivariate normal distribution, although, due to the nature of the
data, we truncated the multivariate normal distribution so that each value was constrained to
fall between 0 and 1. By truncating this way, we obtained a distribution that covers our
desired range, while still retaining some of the mathematically advantageous properties of
the normal distribution.
To glean as much information as we could out of this sparse (i.e., containing a high
proportion of missing values) dataset, we used the observed values to impute missing values.
The algorithm begins by looking at all of the non-missing values to learn about the
relationships among variables. Then it uses those relationships to impute missing values
from the observed values in each row. This is often called “borrowing” information across
observations (e.g., Berry 2006 in a clinical trials setting; Choi et al. 2007 in a meta-analysis).
The data in Table 1 offer a simple non-mathematical example. Roberts and Mann (2000)
reported that both threats to confidentiality and side effects were associated with
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nonadherence (i.e., have a value of 0). Schrimshaw et al. (2005) also found a link between
side effects and nonadherence, but reported nothing about threats to confidentiality. If we
borrowed information from the Roberts and Mann study, we might surmise that there would
also have been a relationship between threats to confidentiality and nonadherence in the
Schrimshaw et al. study. The actual imputation is much more complex than this,
simultaneously borrowing information from all variables at once. Such imputation allows
for relationships among variables, but does not force relationships among variables where
the observed data support none. The imputed values, unlike the real data, are not restricted
to 0, 0.5, and 1, but can take any value ranging from 0 to 1. The imputed values can,
therefore, reflect varying degrees of support for a relationship with adherence/nonadherence,
or the lack of any relationship. For example, an imputed value of 0.75 would support equally
the idea of no relationship (.5) and a relationship with adherence (1).
Another useful feature of Bayesian thinking is that it allows parameters to have statistical
distributions. We were interested in the posterior distributions of the mean vector and the
covariance matrix of the multivariate normal distribution from which each (only partially
observed) row was assumed to have arisen. We used an iterative procedure, known as a
Gibbs Sampling algorithm (Casella and George 1992), which draws samples from the
posterior distributions of the mean and covariance. When a large number of samples has
been obtained, they can be summarized (means, percentiles) to describe the posterior
distribution of the parameters.
Let Y be an n × p matrix of data with missing values and let yi denote the p × 1 vector of
elements in the ith row of the data matrix. yi can be subdivided into missing (unknown)
values, yi,mis (a pi,mis × 1 vector) and observed values, yi,obs (a pi,obs × 1 vector). Note that
pi,mis + pi,obs = p for i = 1, …, n. We assume the following likelihood for each of the n rows
of the data matrix:
where n is the number of reports. TNp (μ, Σ) denotes a p-dimensional multivariate normal
distribution with mean μ and covariance matrix Σ, truncated so that every element falls in
[0,1]. Because not all the elements of yi are observed directly, we have chosen to impute the
missing values at each iteration by using the conditional distribution of the missing elements
on the observed elements. Conditional distributions of the multivariate truncated normal are
multivariate truncated normal (Horrace 2005) so
where the parameters are the same as if it were a non-truncated conditional multivariate
normal distribution: μ and Σ have been partitioned to correspond to the means and
covariances of the observed and missing values. For the ith observation, μi,obs and Σi,obs are
the mean and covariance of the observed values, and μi,mis and Σi,mis are the mean and
covariance of the missing values. The covariance between the elements of yi,mis and yi,obs is
the pi,mis x pi,obs matrix Σi,mo, which is equal to .
The prior structure was developed by putting conjugate priors on μ and Σ:
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Hyperparameters were chosen to carefully balance objectivity and the constraints of the
current problem. Because the posterior distribution of μ should have negligible mass outside
[0,1], values of v that gave samples in this range were preferred. Jeffrey’s joint prior, a
standard non-informative prior, was rejected for violation of this criterion. The prior on μ
was chosen so that it had a mean of 0.5 (i.e. no effect) and was relatively flat when elements
of μ were between 0 and 1. This was accomplished by letting μ0 = .5 *1p, where 1p denotes
a px1 vector of ones and letting κ0 = 10. Various choices for the degrees of freedom, v, of
the prior distribution of Σ were examined. A value of v = 100 was chosen, as it was
determined that this value led to samples in the desired range. Much higher values of v
tended to suppress any correlation between factors, and much lower values tended to
overstate the extent of that correlation. Σ0 was taken to be the diagonal matrix containing the
variances of the columns of Y.
Due to the conjugate prior structure, the full conditional posterior distributions of μ and Σ
were multivariate normal and inverse-Wishart respectively (see Gelman et al. 2004, pp. 87–
88 for details). The Gibbs sampling algorithm proceeded by iteratively sampling the
unobserved elements of the data matrix, yi,mis for i = 1, … , n, from (1), the mean vector, μ,
from its full conditional posterior distribution and the covariance matrix, Σ, from its full
conditional posterior distribution.
The MCMC algorithm was run in Matlab 7.6.0. Ten million samples were taken, and every
hundredth was retained for analysis, for a total of 100,000 samples. The first 10,000 were
discarded as a burn-in, leaving 90,000 for analysis. Convergence and adequate mixing of the
Gibbs Sampler were observed on traceplots of all parameters.
3 Results
Point estimates and credible intervals (the Bayesian analog to confidence intervals) were
constructed by summarizing the 90,000 samples. The point estimate of each mean is the
average over all the samples, and can be used to describe the strength of the relationship
between each factor and adherence/nonadherence. A 95% credible interval for each estimate
is simply the 2.5th and 97.5th percentiles of the 90,000 samples.
As our goal was to determine which factors were associated with adherence/nonadherence,
we examined the point estimates and 95% credible intervals for the means, given in Table 3.
These estimates from the posterior distribution can be interpreted similarly to the point
estimates and confidence intervals for the naive approach shown in Table 2, where an
interval containing 0.5 indicates ambiguity or the possibility of no association. The factors in
Table 3 have been divided into three groups based on the credible intervals: factors
associated with adherence, factors associated with nonadherence, and factors associated with
neither adherence nor nonadherence (or both, yielding an estimate near 0.5). Unlike the
naive analysis presented earlier, this analysis is not prone to the bias and/or low power that
resulted from the construction of normal confidence intervals from small samples.
The research question (identification of factors associated with adherence/nonadherence) is
best answered by looking at the factors listed in Table 3. Based on synthesis of information
from the 12 reports, we identified four factors that promote adherence, four factors that are
unrelated or ambiguously related to adherence, and four factors that hinder adherence.
If we wish to delve more deeply into the relative strength of the relationships, the 90,000
samples can be used to compare the strength of association between the 12 factors and
adherence/nonadherence. We can calculate the exact posterior probability that any factor is
more closely related to adherence/nonadherence than any other factor by comparing the
entire set of samples for the two factors. For example, we might want to examine whether
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the literature supported a stronger relationship between adherence and the belief that
antiretroviral medications might do good than between adherence and a positive social
network. According to Table 3, both credible intervals span values > 0.5, so both of these
factors were associated with adherence. The point estimate for the belief that antiretroviral
medications might do good is higher (.96 vs. .85), but we want to have some idea of the
chance that there actually is a difference. We calculated the posterior probability that the
mean for belief that medications might do good was higher than that for positive social
network. To do this, we used the 90,000 samples from the posterior distribution of the
population mean. We counted how often (i.e., in how many samples) the sampled value for
the belief that antiretroviral medications might do good was higher than that for positive
social network.
As it turned out, the sampled value was higher for the belief that antiretroviral medications
might do good than for positive social network in 88,811 of the 90,000 samples, or 98.7% of
the time. Accordingly, we can be 98.7% confident that the mean for belief that medications
might do good is higher than for positive social network. That is, we are 98.7% confident
that the evidence is more supportive of a relationship between belief that medications might
do good and adherence than between a positive social network and adherence.
This is a type of Bayesian hypothesis testing. It can be thought of more naturally as a
hypothesis test if we calculate posterior probability that the mean for belief that medications
might do good is less than or equal to that for positive social network, which is simply
100%-98.7% = 1.3%. So, there is only a 1.3% chance that the relationship between
adherence and positive social network was equal to or stronger than that between adherence
and belief in effectiveness. This posterior probability is the Bayesian analog to a p-value, so
it is some-times called a Bayesian p-value (Gelman et al. 2004). It is the posterior
probability that there is no real difference in the population and is often interpreted like the
usual (frequentist) p-value by comparing it to a significance level of 5%. If we were doing a
Bayesian significance test by that strict criterion, we would say there is evidence to show
that the relationship between adherence and belief in effectiveness is stronger than that
between adherence and positive social network. However, just as the 5% cutoff for p-values
is rather arbitrary for the frequentist approach, it is for the posterior probability as well. A
researcher would not be unreasonable to use a higher or lower cutoff, or to simply interpret
the probabilities directly with no stated significance level.
This process of comparing samples can be used to assess the relative strength between
adherence and any 2 of the 12 factors, but is not entirely necessary. In general, if the
credible intervals do not overlap, we can be at least 95% confident that there is a difference
between the two means (i.e. the Bayesian p-value will be less than 5%). For example, the
credible intervals for belief that medications might do good (.90, 1.0) and having or living
with children (.46, .64) do not overlap. Therefore, the posterior probability that the mean for
belief that medications might do good is less than or equal to that for having or living with
children is no more than 5% (and likely much smaller than 5%). When an exact posterior
probability is desired, or when the credible intervals do overlap, a pairwise comparison of
the two factors as described above can be performed.
Since non-overlapping credible intervals will always yield a Bayesian p-value of less than
5%, we chose not to calculate Bayesian p-values for these comparisons. Pairwise
comparisons were performed for all pairs of variables with overlapping credible intervals.
There were 21 of those comparisons. Table 4 contains the results for the 11 comparisons
with Bayesian p-values less than .20. The others are omitted from the table for the sake of
brevity. Interpreting the Bayesian hypothesis tests with a significance level of 5%, we
conclude that belief that medications might do good was significantly more associated with
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adherence than any other factors. Positive social network and routinization were not
significantly different in their associations. Positive social network was significantly
different from having or living with children. Routinization was significantly different from
having or living with children and healthy or low virologic load. The two factors associated
with neither adherence nor nonadherence (having or living with children and healthy or low
virologic load) were not significantly different from each other. None of the 5 factors
associated with nonadherence were significantly different from one another.
The Bayesian data augmentation procedure involved estimating a covariance between
findings in a study. Converting these findings to correlations, we can get estimates of (and
credible intervals for) the relationships between findings within a study. We chose not to
discuss the correlations in depth in this paper, but provide a single example here for the
interested reader. The data provide evidence that the correlation between the relationship
between side effects and adherence and the relationship between a complex regimen and
adherence is .25, with a 95% credible interval of (.07, .42). That is, reports citing a
relationship between side effects and adherence would tend to report a similar relationship
between complex regimen and adherence. Other point estimates of correlations ranged from
−.40 to .44. Future work may further examine the implications of this correlation structure
on this or other datasets.
4 Discussion
Those arguing for the applicability of Bayesian analysis to research synthesis often focus
solely on the Bayesian ability to incorporate prior beliefs into an analysis- that is, first
stating prior beliefs about the study question, then updating those beliefs based on evidence
from several research reports. Although the incorporation of prior information is a useful
feature of Bayesian analysis, that was not its main attraction here. In this analysis, we used
fairly non-informative (objective) priors, and exploited instead the innate ability of the
Bayesian approach to borrow information to allow the observed data to inform about
missing values.
We have described a Bayesian method that can be applied to the synthesis of results from
qualitative and quantitative reports. Unlike Roberts et al. (2002), we incorporated the
qualitative and quantitative evidence in the same step of the analysis (rather than using
qualitative reports only as prior information). This means that the data from each report,
whether qualitative or quantitative, is treated the exact same way in the model. In contrast to
Voils et al. (2009), which synthesized data at the participant level by linking findings to the
numbers of participants expressing them, we synthesized data at the study level, by
designating themes as present or absent, rather than at the subject level whereby findings are
linked to numbers of subjects expressing them.
To our knowledge, the current analysis is the first Bayesian synthesis of qualitative and
quantitative research that allows for an explicit comparison of the strength of association
among a set of factors being studied. We were able to examine the individual and relative
effects of 12 different factors on adherence. Roberts et al. (2002) examined multiple factors,
but looked at the relationships of each with the outcome as mutually exclusive events (in
Bayesian terms, a major limitation of their analysis). Voils et al. (2009) estimated the
probability of an association between medication regimen complexity and non-adherence in
a single subject, but has not yet been expanded to account for multiple factors
simultaneously.
The rigorous analysis did not yield more interesting results than the naive analysis simply by
virtue of being Bayesian. The naive analysis was a frequentist (non-Bayesian) analysis, but a
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Bayesian analysis with a non-informative prior that did not borrow information across
studies would have yielded identical results to the naive frequentist analysis. The frequentist
approach was presented because it was simpler in implementation and explanation.
The data matrix was constructed by characterizing the presence (or absence) of themes in
each report. Tabulating the results in reports of qualitative and quantitative studies according
to the presence or absence of results is not new. For example, Mills et al. (2006b) reviewed
the literature with the intent to describe typical barriers to participation in cancer clinical
trials. They amassed a list of themes across the reports they reviewed and then categorized
each theme as either present or absent in each research report. In contrast to this
dichotomous 0/1 scheme, our coding scheme has a distinct advantage in that it distinguishes
between variables not studied and variables that were studied, but for which no association
was found. In Mills et al. 2006b, unstudied relationships were treated as equivalent to
findings of no relationships. This could lead to bias toward relationships that have been
more frequently studied. Our use of missing data methods to account for unstudied/
unreported factors parallels what is often done in primary studies to account for unmeasured
variables.
Alhough our coding scheme successfully separated findings of no relationship from
unstudied findings, it is still limited in that it did not separate factors unassociated with
adherence from those factors associated with both adherence and nonadherence. For
example, a finding from the qualitative studies was that having or living with children
promoted adherence when it gave the woman a purpose in life, but hindered adherence when
child care interfered with her ability to care for herself (e.g., Edwards 2006; Powell-Cope et
al. 2003). Although it did not happen in this set of reports, if both of those findings were
reported in a single study, the relationship would be coded as .5, the same as no association.
From a clinical standpoint, this number does not adequately describe the nature of the
relationship between having or living with children and adherence.
Tabulation of results in this way lends itself well to the qualitative reports as there is no need
to infer information (i.e., actual frequency counts) that is not explicitly present in them (and
may not be available from authors). Moreover, this approach is more in line with the
qualitative research imperative to include all findings, even those expressed by only one
participant. This approach may be less advantageous for quantitative reports, however, as it
involves dichotomizing a finding that is generally reported with a p-value, effect size, or
some other measure of the strength of effect; such dichotomization results in the loss of
information. Future projects may relax the restriction of values to 0, 0.5, and 1, allowing for
a more continuous value to capture varying degrees of association.
The data augmentation model we used in certainly not the only model, and different models
or different adaptations of this model should be considered in the future. We used a
truncated normal likelihood, but we also considered defining a latent variable folded-normal
likelihood, where all the mass above one is put on 1 and all the mass below 0 is put on 0, as
in Albert and Chib (1993). We chose not to do this because the inflation on 1 and 0 might
bias toward strong associations, but in some settings those inflations might be desirable. A
potential limitation to flexibility of the data augmentation model is the choice of the inverse-
Wishart distribution to model the covariance. In any study where the goal is to draw
inferences about specific elements of the covariance matrix, a more flexible distribution
should be considered.
Finally, the application of this method did not require both qualitative and quantitative
studies, as every study was treated the same. Although we did not include any factors not
studied in both quantitative and qualitative reports, this was not a necessary modeling
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decision. In fact, the imputation of missing values that borrows information across studies
makes this method uniquely suited to the case where a variable is more heavily covered in
qualitative or quantitative studies. Future applications of this method need not focus on the
qualitative/quantitative nature of each study, but rather seek to include all studies covering
variables of interest regardless of the study methodology.
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Table 2










Belief that antiretroviral medication might do good 7 .93 (.79, 1.07) (.79, 1)
Positive social network 11 .81 (.67, .97) (.67, .97)
Routinization 4 .75 (.26, 1.24) (.26, 1)
Having or living with children 6 .58 (.19, .98) (.19, .98)
Healthy or low virologic load 2 .50 (−.48, 1.48) (0, 1)
More complex regimen 5 .20 (−.19, .59) (0, .59)
Side effects/feeling ill 12 .17 (−.02, .35) (0, .35)
Disclosure/stigma/threats to confidentiality 7 .14 (−.14, .42) (0, .42)
Negative feelings 5 .10 (−.10, .30) (0, .3)
Belief that antiretroviral medications might do harm 6 .08 (−.08, .25) (0, .25)
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Table 3












 medication might do good
.96 (.90, 1.0) (.79,1)
Positive social network .85 (.76, .94) (.67,.97)





Having or living with children .64 (.45, .83) (.19,.98)
Healthy or low virologic load .62 (.29, .90) (0,1)
Factors associated
 with nonadherence
More complex regimen .29 (.11, .48) (0,.59)
Disclosure/stigma/threats to
 confidentiality
.21 (.07, .36) (0,.42)
Side effects/ feeling ill .21 (.09,.32) (0,.25)
Negative feelings .19 (.10,.29) (0,.3)
Belief that antiretroviral
 medication might do harm
.16 (.08, .25) (0,.25)













Crandell et al. Page 18
Table 4
Selected pairwise comparisons between factors with overlapping credible intervals
Factor 1 Factor 2 Number of samples in
which Factor 1 had





 medication might do
good
Positive social network 88,811 .01*
Having or living with children More complex regimen 89,532 .01*
Healthy or low virologic load Disclosure/stigma/threats to
 confidentiality
88,773 .01*
Healthy or low virologic load Side effects/feeling ill 89,103 .01*
Positive social network Having or living with children 87,388 .03*
Healthy or low virologic load More complex regimen 86,040 .04*
Positive social network Healthy or low virologic load 83,360 .07
More complex regimen Belief that antiretroviral
 medication might do
 harm
81,550 .09
Routinization Having or living with children 77,991 .13
Routinization Healthy or low virologic load 75,799 .16
More complex regimen Negative feelings 75,100 .17
Ten pairs of factors with overlapping credible intervals had a Bayesian p-value above .20 and are not included in this table Bayesian p-value <.05
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